PSMA8
Basic information
Region (hg38): 18:26133852-26193355
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PSMA8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 18 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 1 | 0 |
Variants in PSMA8
This is a list of pathogenic ClinVar variants found in the PSMA8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-26133984-A-T | not specified | Uncertain significance (Sep 07, 2022) | ||
18-26134044-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
18-26134055-A-C | not specified | Uncertain significance (Oct 10, 2023) | ||
18-26134066-C-T | not specified | Uncertain significance (Dec 28, 2023) | ||
18-26144582-A-G | not specified | Uncertain significance (Apr 26, 2024) | ||
18-26144583-G-C | not specified | Uncertain significance (Feb 06, 2023) | ||
18-26144626-A-G | not specified | Uncertain significance (Jul 25, 2023) | ||
18-26144659-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
18-26144679-T-G | not specified | Uncertain significance (Jun 17, 2024) | ||
18-26151854-A-G | not specified | Likely benign (Oct 04, 2022) | ||
18-26151896-C-T | not specified | Uncertain significance (Oct 10, 2023) | ||
18-26151897-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
18-26151903-A-G | not specified | Uncertain significance (Oct 17, 2023) | ||
18-26151918-A-G | not specified | Uncertain significance (Jun 28, 2023) | ||
18-26158233-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
18-26178846-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
18-26178921-T-C | not specified | Uncertain significance (Sep 14, 2022) | ||
18-26178933-T-G | not specified | Uncertain significance (Aug 02, 2023) | ||
18-26179117-A-G | not specified | Uncertain significance (Nov 08, 2022) | ||
18-26192332-A-G | not specified | Uncertain significance (Aug 19, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PSMA8 | protein_coding | protein_coding | ENST00000308268 | 7 | 59504 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000550 | 0.892 | 125716 | 0 | 32 | 125748 | 0.000127 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.368 | 126 | 138 | 0.912 | 0.00000721 | 1654 |
Missense in Polyphen | 70 | 74.17 | 0.94378 | 876 | ||
Synonymous | -0.122 | 48 | 46.9 | 1.02 | 0.00000253 | 494 |
Loss of Function | 1.49 | 9 | 15.3 | 0.588 | 0.00000103 | 161 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000617 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000178 | 0.000176 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000166 | 0.000163 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the spermatoproteasome, a form of the proteasome specifically found in testis that promotes degradation of histones, thereby participating actively to the exchange of histones during spermatogenesis. The proteasome is a multicatalytic proteinase complex which is characterized by its ability to cleave peptides with Arg, Phe, Tyr, Leu, and Glu adjacent to the leaving group at neutral or slightly basic pH (By similarity). {ECO:0000250}.;
- Pathway
- Proteasome - Homo sapiens (human);Post-translational protein modification;Metabolism of proteins;UCH proteinases;Neddylation;Ub-specific processing proteases;Deubiquitination
(Consensus)
Recessive Scores
- pRec
- 0.142
Intolerance Scores
- loftool
- 0.630
- rvis_EVS
- -0.14
- rvis_percentile_EVS
- 43.29
Haploinsufficiency Scores
- pHI
- 0.0625
- hipred
- N
- hipred_score
- 0.487
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.798
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Psma8
- Phenotype
Gene ontology
- Biological process
- proteasomal protein catabolic process;proteasomal ubiquitin-independent protein catabolic process;protein deubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- nucleus;cytoplasm;cytosol;proteasome core complex;proteasome core complex, alpha-subunit complex;extracellular exosome;spermatoproteasome complex
- Molecular function
- endopeptidase activity;threonine-type endopeptidase activity